AGEN Presents Survival Data
Agenus announces three-year survival data from Phase 1b BOT+BAL study in MSS metastatic colorectal cancer to be presented at ESMO GI 2026
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.